Clinical Trial

Insights Into Participating in Studies for Uterine Cancer

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 21, 2023 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.
Summary
Clinical study participation has historically been heavily biased toward specific demographics. Several people will be invited to enroll in this trial so that it may collect a variety of data about uterine cancer clinical study experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal. People with uterine cancer who are invited to take part in medical study will benefit from the analysis of the data.
Trial Details
NCT Number NCT05998811
Lead Sponsor Power Life Sciences Inc.
Conditions Uterine Cancer
Enrollment 500 participants
Start Date 2024-09
Primary Completion 2025-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2023-08-21